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Introduction
The eukaryotic oligosaccharyltransferase (OST) transfers pre-
assembled oligosaccharides onto asparagine residues as nascent 
polypeptides are translocated across the rough ER membrane 
(for review see Kelleher and Gilmore, 2006). The consensus site 
for N-linked glycosylation in eukaryotic organisms is conserved 
and corresponds to the simple tripeptide sequence N-X-T/S, 
where X can be any residue except proline (Gavel and Von 
Heijne, 1990).
The oligosaccharide donor assembled by most eukaryotes 
for N-linked glycosylation is the dolichol pyrophosphate–linked 
oligosaccharide Glc3Man9GlcNAc2-PP-Dol (abbreviated here 
as G3M9GN2-PP-Dol). Synthesis of the dolichol-linked oligo-
saccharide (OS-PP-Dol) donor occurs by the stepwise addition 
of monosaccharide residues onto the dolichol-pyrophosphate 
carrier by a family of ER-localized membrane bound glycosyltrans-
ferases (asparagine-linked glycosylation [ALG] gene products; 
for review see Burda and Aebi, 1999). Man5GlcNAc2-PP-Dol 
(M5GN2-PP-Dol) is assembled on the cytoplasmic face of the 
ER membrane, with UDP-GlcNAc and GDP-Man serving as 
monosaccharide donors. Man-P-Dol and Glc-P-Dol are the do-
nors for the luminally oriented glycosyltransferases that add 
four mannose and three glucose residues to OS-PP-Dol assem-
bly intermediates within the ER lumen. Depletion of the yeast 
Rft1 protein causes severe hypoglycosylation of proteins and 
accumulation of Man5GlcNAc2-PP-Dol (Helenius et al., 2002) 
even though Alg3p, not Rft1p, is the mannosyltransferase that 
adds the sixth mannose residue. Rft1p has been proposed to fl ip 
cytosolically oriented M5GN2-PP-Dol across the ER membrane 
(Helenius et al., 2002).
Certain kinetoplastids (Trypanosoma cruzi and Leishmania 
mexicana) and the ciliate Tetrahymena pyriformis assemble 
OS-PP-Dol compounds that lack the glucose residues (M9GN2-
PP-Dol by T. cruzi) and/or the mannose residues (G3M5GN2-
PP-Dol by T. pyriformis and M6GN2-PP-Dol by L. mexicana) 
that are transferred by the luminally oriented ALG gene prod-
ucts (de la Canal and Parodi, 1987; Parodi, 1993). Searches of 
fully sequenced genomes using yeast ALG proteins as query 
sequences has revealed considerable diversity in OS-PP-Dol 
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bio synthesis amongst unicellular organisms (Samuelson et al., 
2005). Biochemical studies have confi rmed bioinformatic predic-
tions that Giardia lamblia synthesizes GN2-PP-Dol, Trichomonas 
vaginalis and Entamoeba histolytica synthesize M5GN2-PP-Dol, 
and the pathogenic fungi Cryptococcus neoformans  synthesizes 
M9GN2-PP-Dol (Fig. 1; Samuelson et al., 2005). The diversity 
of eukaryotic OS- PP-Dol donors was proposed to have  occurred 
by secondary loss of ALG genes during the evolution of current 
eukaryotes from a last common ancestor with a complete ALG 
pathway (Samuelson et al., 2005).
In fungi and vertebrate organisms, the OST is an oligomer 
composed of seven to eight nonidentical subunits (for review see 
Kelleher and Gilmore, 2006). Of the eight Saccharomyces cere-
visiae OST subunits (Stt3p, Ost1p, Ost2p, Ost3p or Ost6p, Ost4p, 
Ost5p, Wbp1p, and Swp1p), fi ve are encoded by essential yeast 
genes (STT3, OST1, OST2, WBP1, and SWP1). With the excep-
tion of STT3, which contains the enzyme active site (Yan and 
Lennarz, 2002; Kelleher et al., 2003; Nilsson et al., 2003), rela-
tively little is known about the roles of the essential or non-
es sential subunits (for review see Kelleher and Gilmore, 2006). 
Vertebrate, plant, and insect genomes encode two forms of the 
catalytic subunit that are designated as STT3A and -B (Kelleher 
et al., 2003; Koiwa et al., 2003). The canine STT3 homo -
logues are assembled with a shared set of noncatalytic subunits 
(ribophorin I [Ost1 homologue], ribophorin II [Swp1], OST48 
[Wbp1], DAD1 [Ost2], and TUSC3 or IAP [Ost3 or -6] and 
OST4) to generate OST isoforms with kinetically distinct proper-
ties (Kelleher et al., 2003). Protein and DNA sequence database 
searches of fully sequenced eukaryotic genomes using the yeast 
and human OST subunits as query sequences suggest that the 
OST in protist organisms has a simpler subunit composition (Fig. 
1; Kelleher and Gilmore, 2006). The genomes of G. lamblia and 
the kinetoplastids T. cruzi and Trypanosoma brucei encode sev-
eral different STT3 proteins (Samuelson et al., 2005), yet lack 
genes encoding the noncatalytic subunits. Four-subunit com-
plexes, consisting of STT3, OST1, OST2, and WBP1, are pre-
dicted for T. vaginalis and E. histolytica. A six-subunit complex 
(STT3, OST1, OST2, OST3, OST4, and WBP1) is predicted for 
Cryptosporidium parvum. The C. neoformans genome encodes 
readily identifi able homologues of all S. cerevisiae OST subunits 
with the exception of Ost5p (Fig. 1).
The absence of glucose residues on OS-PP-Dol com-
pounds assembled by most protists and C. neoformans is of 
particular interest because the terminal glucose residue on 
G3M9GN2-PP-Dol is a critical substrate recognition determinant 
for the OST. OS-PP-Dol assembly intermediates that lack the 
terminal glucose residue are transferred less rapidly by the ver-
tebrate and yeast OST (Turco et al., 1977; Trimble et al., 1980; 
Bosch et al., 1988; Karaoglu et al., 2001; Kelleher et al., 2003), 
thereby minimizing synthesis of glycoproteins with aberrant 
oligosaccharide structures. Glycosylation of proteins with an 
oligosaccharide assembly intermediate could interfere with 
glycoprotein quality-control pathways in the ER as well as 
sub sequent oligosaccharide-processing reactions in the Golgi 
complex (for review see Helenius and Aebi, 2004). Cellular 
defects in G3M9GN2-PP-Dol biosynthesis cause a family of in-
herited diseases (congenital disorders of glycosylation [CDG-I]) 
due to hypoglycosylation of nascent glycoproteins by the 
OST in cells that accumulate an assembly intermediate or are 
unable to maintain a normal concentration of fully assembled 
G3M9GN2-PP-Dol (for review see Freeze and Aebi, 2005).
Preferential utilization of G3M9GN2-PP-Dol by the yeast and 
vertebrate OST occurs by allosteric interactions between a regula-
tory OS-PP-Dol binding site and the active site subunit, as well as 
by oligosaccharide structure–mediated alterations in tripeptide ac-
ceptor binding affi nity (Karaoglu et al., 2001; Kelleher et al., 2003). 
Kinetic analysis of the purifi ed canine OST  isoforms has suggested 
that the regulatory OS-PP-Dol binding site is not located on STT3A 
or -B, but is instead associated with one or more of the noncatalytic 
subunits (Kelleher et al., 2003).
Does the OST from organisms that synthesize nonglucosyl-
ated OS-PP-Dols transfer the in vivo donor in preference to OS-
PP-Dol assembly intermediates or G3M9GN2-PP-Dol? Previous 
studies indicate that the T. cruzi OST transfers glucosylated 
(G1-3M9GN2-PP-Dol) and large nonglucosylated (M7-9GN2-PP-Dol) 
donors at similar rates in vitro (Bosch et al., 1988), suggesting 
that the T. cruzi OST is nonselective. Can biochemical analysis of 
the OST from primitive eukaryotes reveal properties of the higher 
eukaryotic OST that arose as additional subunits were added 
to the STT3 catalytic core? Here, we report a comparison of 
the OST from T. vaginalis, E. histolytica, T. cruzi, C. neoformans, 
and S. cerevisiae, with emphasis placed upon an analysis of donor 
Figure 1. OS-PP-Dol donors and predicted subunit compositions of the 
OST from selected eukaryotes. The left portion of A–D shows the oligosac-
charide structure of the in vivo donor for N-linked glycosylation. N-acetyl-
glucosamine residues are designated by squares, mannose residues are 
shown as circles, and glucose residues are shown as triangles. Red sac-
charides are transferred by cytoplasmically oriented ALG gene products, 
and blue residues are transferred by luminally oriented ALG gene products. 
The right section of each panel shows the predicted (A, T. cruzi; B, C. neo-
formans; or C, T. vaginalis and E. histolytica) or experimentally determined 
(D, S. cerevisiae) composition of the OST complex. The color code of the 
subunits (red, green, and blue) designates subcomplexes detected in higher 
eukaryotes (Karaoglu et al., 1997; Spirig et al., 1997). The yellow bar 
designates the ER membrane.
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substrate selection. Our results support the hypothesis that termi-
nal mannose residues on the OS-PP-Dol are important for donor 
substrate recognition by the OST in organisms that assemble non-
glucosylated OS-PP-Dol compounds. Cooperative OS-PP-Dol 
binding, a feature of the yeast and canine OST complex that fa-
cilitates exquisite G3M9GN2-PP-Dol selection, is not a property 
of the predicted one- and four-subunit protist OST complexes.
Results
Donor substrate selection by the OST
Is preferential utilization of the in vivo oligosaccharide donor 
an OST property that is restricted to eukaryotes that assemble 
triglucosylated OS-PP-Dols? To address this question, the OST 
from selected protists and C. neoformans was assayed using 
a synthetic tripeptide acceptor and a heterogeneous bovine OS-
PP-Dol library that consists of donors that range in size between 
M3GN2-PP-Dol and G3M9GN2-PP-Dol. Enzyme concentrations 
were adjusted to ensure that a maximum of 3% of the total do-
nor substrate was converted into glycopeptides. Radiolabeled 
glycopeptide products that were captured with an immobilized 
lectin (ConA Sepharose) were subsequently eluted and resolved 
by high-pressure liquid chromatography (HPLC) according 
to the number of saccharide residues (Fig. 2). As expected, 
G3M9GN2-NYT was the most abundant product when the puri-
fi ed S. cerevisiae OST was assayed (Fig. 2 A). In contrast, 
G3M9GN2-NYT was less abundant in the T. cruzi glycopeptide 
products (Fig. 2 B) and barely detectable in glycopeptide prod-
ucts derived from assays of the T. vaginalis (Fig. 2 C), C. neo-
formans (Fig. 2 D), or E. histolytica (not depicted) OST. The 
composition of the OS-PP-Dol donor library was determined as 
described previously (Kelleher et al., 2001) by incubating an 
excess of the purifi ed yeast OST with a low quantity of the do-
nor substrate (OST endpoint assay; Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200611079/DC1). A normal-
ized initial transfer rate (glycosylated tripeptide [OS-NYT]/
OS-PP-Dol; Fig. 2, E and F) was calculated for the eight most 
abundant donors by dividing the glycopeptide product composi-
tion by the composition of the OS-PP-Dol donor substrate 
 library. A normalized initial transfer rate of 1 (Fig. 2, E and F, 
dashed lines) indicates nonselective utilization of a donor sub-
strate relative to the total donor pool.
The T. vaginalis and E. histolytica OST transfer the man-
nosylated donors (M4-9GN2-PP-Dol) threefold more rapidly than 
G3M9GN2-PP-Dol (Fig. 2, E and F). Although the T. cruzi OST 
utilizes compounds ranging in size between M7GN2-PP-Dol and 
G3M9GN2-PP-Dol at rates similar to those reported previously 
(Bosch et al., 1988), OS-PP-Dol donors with fewer mannose 
residues (M3-6GN2-PP-Dol) were transferred less rapidly (Fig. 2 F). 
The C. neoformans OST showed preferential utilization of the in 
vivo donor (M9GN2-PP-Dol) relative to assembly intermediates 
(M3-6GN2-PP-Dol) and the glucosylated donor (Fig. 2 F).
Structural determinants of donor 
substrate selection
Careful inspection of the glycopeptide elution profi les (Fig. 2, 
A–D) revealed that several of the smaller glycopeptide peaks 
(e.g., M5GN2-NYT) have prominent shoulders, suggesting oli-
gosaccharide structural heterogeneity. The structural diversity 
of the OS-PP-Dol donor substrate library is thought to arise by 
exposure of G3M9GN2-PP-Dol to cellular glucosidases and 
mannosidases during isolation (Kelleher et al., 2001). Mannos-
idase degradation of M9GN2-PP-Dol (Fig. 3 A, compound a) 
could yield seven M5GN2-PP-Dol isomers (Fig. 3 A, com-
pounds c–i) that differ from biosynthetic M5GN2-PP-Dol (Fig. 
3 A, compound b). Biosynthetic M5GN2-PP-Dol (Fig. 3 A, 
compound b) can be readily distinguished from these other 
isomers by digestion with α-1,2 mannosidase, as it is the only 
isomer that has two α-1,2–linked mannose residues (Fig. 3 A, 
red circles). M5GN2 glycopeptides produced in an OST end-
point assay were purifi ed by preparative HPLC (Fig. 3 B, left) 
and digested to completion with α-1,2 mannosidase. Resolution of 
Figure 2. Donor substrate selection from an OS-PP-Dol library. The puriﬁ ed 
yeast OST (A) or detergent extracts prepared from T. cruzi (B), T. vaginalis 
(C), C. neoformans (D), or E. histolytica (not depicted) membranes were 
assayed for OST activity in the presence of glucosidase and mannosidase 
inhibitors using 1.2 μM OS-PP-Dol and 10 μM tripeptide acceptor (Nα-Ac-
N-[125I]-Y-T NH2). Glycopeptide products ranging in size between M3GN2-
NYT (M3) and G3M9GN2-NYT (G3) were resolved by HPLC and identiﬁ ed 
by migration relative to authentic standards (M5, M9, and G3). (E and F) 
The normalized initial transfer rate (OS-NYT/OS-PP-Dol) for the eight most 
abundant OS-PP-Dol donors was calculated by dividing the composition 
of the glycopeptide products by the composition of the OS-PP-Dol donor 
library. The OST from all organisms was assayed twice to determine the 
composition of the product pool. The composition of the donor pool was 
determined by duplicate assays (Fig. S1, available at http://www
.jcb.org/cgi/content/full/jcb.200611079/DC1). Note the difference in 
ordinate scales for E and F.
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the digestion products by HPLC (Fig. 3 B, right) yielded three 
peaks (M3, M4, and M5) that are derived from M5GN2-PP-
NYT isomers that contain 2, 1, or 0 α-1,2–linked man nose 
residues. Quantifi cation (Fig. 3 D, black bars) of two indepen-
dent experiments revealed that 22% of the M5GN2 glycopep-
tides were derived from biosynthetic M5GN2-PP-Dol (Fig. 3 A, 
compound b), 63% from compounds c–h, and 15% from 
compound i.
If the OST from T. vaginalis, E. histolytica, T. cruzi, or 
S. cerevisiae selects biosynthetic M5GN2-PP-Dol (Fig. 3 A, 
com pound b) in preference to other M5GN2-PP-Dol isomers, 
the M5GN2 glycopeptides synthesized in the presence of excess 
donor substrate should be enriched in glycopeptides that con-
tain two α-1,2–linked mannose residues. To ensure that our gly-
copeptide product analysis provided a reliable measure of the 
relative initial transfer rate, the OST assays were terminated 
when <10% of the total M5GN2-PP-Dol was converted into 
glycopeptides. Typical HPLC profi les of the α-1,2 mannosidase 
digestion products of the M5GN2 glycopeptides are shown in 
Fig. 3 C, and the results from assays of all four organisms are 
quantifi ed in Fig. 3 D. We observed a very similar distribution 
of M5GN2 isomers for the donor substrate pool and the initial 
S. cerevisiae glycopeptide products (Fig. 3 D, compare black and 
white bars), thereby indicating that the S. cerevisiae OST does 
not discriminate between M5GN2-PP-Dol isomers. The M5GN2 
glycopeptides synthesized by the T. vaginalis and E. histolytica 
OST also resembled the M5GN2-PP-Dol donor pool; hence, the 
OST from these organisms does not select biosynthetic M5GN2-
PP-Dol in preference to other M5GN2-PP-Dol isomers (Fig. 3 D). 
M5GN2 glycopeptides synthesized by the T. cruzi OST were 
twofold defi cient in biosynthetic M5GN2-NYT and enriched in 
one or more M5GN2-NYT isomers that have one α-1,2–linked 
mannose residue (Fig. 3 D). This result, taken together with a 
reduced transfer rate for M3-6GN2-PP-Dol relative to M7-9GN2-
PP-Dol (Fig. 2 F) by the T. cruzi OST suggests that a terminal 
α-1,2–linked mannose residue on the B or C antennae of M9GN2-
PP-Dol serves as a positive determinant for substrate selection 
by the T. cruzi OST.
Donor substrate competition experiments were conducted 
using purifi ed biosynthetic M5GN2-PP-Dol (Fig. 3 A, isomer b), 
M9GN2-PP-Dol (Fig. 3 A, compound a), and G3M9GN2-PP-Dol. 
The T. vaginalis OST will synthesize G3M9GN2-NYT when 
G3M9GN2-PP-Dol is the sole donor substrate (Fig. 4 A, profi le a). 
The absence of the M5GN2-NYT product indicates that the 
endogenous donor substrate is not abundant in the assay mix 
relative to the exogenous donor substrate. Analogous results 
were obtained using detergent extracts prepared from T. cruzi, 
E. histolytica, and C. neoformans (unpublished data). When the 
M5GN2-PP-Dol/ G3M9GN2-PP-Dol ratio is 2.5:1, the yeast OST 
primarily synthesized G3M9GN2-NYT, unlike the T. vaginalis 
OST that synthesized M5GN2-NYT (Fig. 4 A, profi les b and c). 
Quantifi cation of this competition experiment, as well as additional 
assays containing 1.5 μM M5GN2-PP-Dol and variable con-
centrations of G3M9GN2-PP-Dol, showed that donor substrate 
selection by the T. vaginalis (Fig. 4 B, squares) and S. cerevisiae 
(Fig. 4 B, circles) OST occurs across a wide range of donor sub-
strate ratios (Fig. 4 B). Additional donor substrate competition 
experiments were conducted using 1:1 mixtures of the three puri-
fi ed oligosaccharide donors (Fig. 4, C–E). The S. cerevisiae OST 
selects G3M9GN2-PP-Dol in preference to both non glucosylated 
donors (Fig. 4, C and D) but does not discriminate between 
M5GN2-PP-Dol and M9GN2-PP-Dol (Fig. 4 E). The OST from 
E. histolytica and T. vaginalis selects both  nonglucosylated 
Figure 3. Reduced transfer of biosynthetic M5GN2-PP-Dol by the T. cruzi 
OST. (A) Biosynthetic M5GN2-PP-Dol (b) and M5GN2-PP-Dol isomers (c–i) 
produced by mannosidase digestion of M9GN2-PP-Dol (a). GlcNAc resi-
dues are indicated by squares, α-1,2–linked mannose residues are indi-
cated by red circles, and α-1,3– and α-1,6–linked mannose residues are 
indicated by open circles. (B) Glycopeptide products obtained in an OST 
endpoint assay (>95% conversion of OS-PP-Dol to OS-NYT) were resolved 
by preparative HPLC to isolate the M5GN2-NYT glycopeptide (left). HPLC 
resolution of the α-1,2 mannosidase digestion products derived from 
M5GN2-NYT (right). The M3GN2-NYT (M3) peak is derived from isomer b, 
the M4GN2-NYT (M4) peak is derived from isomers c–h, and the M5GN2-
NYT (M5) peak corresponds to isomer i. (C) HPLC proﬁ les of α-1,2 mannos-
idase digestion products derived from M5GN2-NYT synthesized by the 
E. histolytica and T. cruzi OST. Redigestion of the M4 peak with a-1,2 mannos-
idase did not yield smaller products (not depicted); hence, the initial diges-
tion had gone to completion. (D) The distribution of the three isomer classes 
(2, 1, or 0 α-1,2–linked mannose residues) was calculated for the total 
M5GN2-PP-Dol pool (OS) and for M5GN2-NYT synthesized by the 
S. cerevisiae (Sc), T. cruzi (Tc), E. histolytica (Eh), and T. vaginalis (Tv) OST. 
Values for the OS, Sc, and Tc are means of two independent experiments; 
error bars designate one of two independent data points. The OS values 
are derived from two replicates of B.
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 donors in preference to G3M9GN2-PP-Dol (Fig. 4, C and D) but 
does not discriminate between M5GN2-PP-Dol and M9GN2-PP-
Dol (Fig. 4 E). The T. cruzi OST does not discriminate between 
M9GN2-PP-Dol and G3M9GN2-PP-Dol (Fig. 4 D), but both 
donors are selected in preference to M5GN2-PP-Dol (Fig. 4, 
C and E). In contrast, both the glucosylated donor and biosyn-
thetic M5GN2-PP-Dol are nonoptimal donors for the C. neoformans 
OST relative to the in vivo donor (Fig. 4, D and E).
The observation that G3M9GN2-PP-Dol but not M9GN2-
PP-Dol is a nonoptimal donor for the T. vaginalis and E. histo-
lytica OST suggests that the A antennae of M5GN2-PP-Dol may 
be recognized by the OST in these organisms. To test this 
 hypothesis, an additional competition experiment was performed 
using a mixture of purifi ed M5GN2-PP-Dol and an enriched 
sample of G2M9GN2-PP-Dol. The G2M9GN2-PP-Dol prepara-
tion contains G1M9GN2-PP-Dol as a minor component. Glyco-
peptide products synthesized by the S. cerevisiae and T. vaginalis 
OST were resolved by HPLC (Fig. 4 F, top). The initial transfer 
rates of 1 for the S. cerevisiae OST serves as an important 
control for the observed lower transfer rates of G2M9GN2-PP-
Dol and G1M9GN2-PP-Dol relative to M5GN2-PP-Dol by the 
T. vaginalis OST. Each additional glucose residue on the A 
branch of the oligosaccharide reduces the normalized initial 
transfer rate by the T. vaginalis OST.
Kinetic parameters for 
the OS-PP-Dol donor
Enzyme kinetic experiments suggest that selection of the fully 
assembled OS-PP-Dol by the yeast or mammalian OST occurs 
by allosteric communication between a regulatory OS-PP-Dol 
binding site and the donor substrate binding site on STT3, in 
addition to oligosaccharide structure–dependent alterations in 
tripeptide substrate binding affi nity (Karaoglu et al., 2001; 
Kelleher et al., 2003). Nonlinear Lineweaver-Burk plots for the 
OS-PP-Dol substrate are diagnostic of the cooperative OS-PP-
Dol binding kinetics of the yeast and mammalian OST (Karaoglu 
et al., 2001). Donor substrate saturation experiments for the 
T. vaginalis (Fig. 5 A), E. histolytica (Fig. 5 C), and T. cruzi 
enzymes (Fig. 5 D) were conducted using a constant concentra-
tion of tripeptide acceptor and increasing concentrations of 
purifi ed OS-PP-Dols. The linear Lineweaver-Burk plots yielded 
Km values in the submicromolar range for the in vivo donor 
 substrate. The experimental data for the T. vaginalis OST was 
replotted as an Eadie-Hofstee plot (Fig. 5 B). The linear 
Eadie-Hofstee plot for the T. vaginalis OST is inconsistent 
with cooperative OS-PP-Dol binding kinetics. In contrast, the 
S. cerevisiae OST binds the same donor substrate (M5GN2-PP-Dol) 
in a cooperative manner, as revealed by a nonlinear Eadie-
Hofstee plot (Fig. 5 B, inset). Additional donor substrate satura-
tion experiments using the nonoptimal donors (M5GN2-PP-Dol 
for T. cruzi OST and G3M9GN2-PP-Dol for T. vaginalis OST) 
did not reveal differences in the apparent Km that could account 
for the lower transfer rates of the nonoptimal donor substrate 
(unpublished data). Donor substrate selection by the protist 
OST does not involve a regulatory OS-PP-Dol binding site, nor 
is it explained by a reduced affi nity for the nonoptimal oligosac-
charide donor.
Kinetic parameters for the tripeptide 
substrate acceptor
Reduced transfer rates for nonoptimal donors by the yeast and 
mammalian OST is in part explained by a reduced binding af-
fi nity for the tripeptide acceptor in the presence of an OS-PP-
Dol assembly intermediate (Breuer and Bause, 1995; Gibbs and 
Coward, 1999; Karaoglu et al., 2001; Kelleher et al., 2003). The 
T. vaginalis (Fig. 6 A) and T. cruzi (Fig. 6 B) OST were assayed 
in the presence of a constant concentration of the optimal and 
nonoptimal oligosaccharide donors and increasing concentrations 
Figure 4. Oligosaccharide donor competition assays. OST activity was 
assayed using a constant concentration of the acceptor tripeptide (5 μM in 
A, B, and F and 10 μM in C–E). (A) Glycopeptide products from assays of 
the T. vaginalis (a and c) or S. cerevisiae (b) OST using 1 μM G3M9GN2-
PP-Dol (a) or 0.6 μM G3M9GN2-PP-Dol plus 1.5 μM M5GN2-PP-Dol (b and c) 
were resolved by HPLC. For clarity, column proﬁ les have been offset on the 
vertical axis. (B) The T. vaginalis (squares) or S. cerevisiae (circles) OST 
were assayed using 1.5 μM M5GN2-PP-Dol and increasing concentrations 
of G3M9GN2-PP-Dol. Glycopeptide products were resolved by HPLC to de-
termine the percentage of M5GN2-NYT. The dashed line indicates the com-
position (in percentage of M5GN2-PP-Dol) of the donor substrate mixtures. 
(C–E) Puriﬁ ed S. cerevisiae (Sc) or detergent extracts of C. neoformans 
(Cn), E. histolytica (Eh), T. vaginalis (Tv), or T. cruzi (Tc) membranes were 
assayed using the following donor substrate mixtures: 1 μM G3M9GN2-PP-
Dol + 1 μM M5GN2-PP-Dol (C), 1 μM G3M9GN2-PP-Dol + 1 μM M9GN2-PP-
Dol (D), and 1 μM M9GN2-PP-Dol + 1 μM M5GN2-PP-Dol (E). Glyco peptides 
were resolved by HPLC to determine product composition. (F) The S. cere-
visiae and T. vaginalis OST were assayed using the following mixture: 
(G2M9GN2-PP-Dol/G1M9GN2-PP-Dol/M9GN2-PP-Dol/M5GN2-PP-Dol, 
35:6:2:57). Glycopeptides were resolved by HPLC (top). The M5GN2-NYT 
(M5), G1M9GN2-NYT (G1), and G2M9GN2-NYT (G2) peaks are labeled. 
The T. vaginalis OST (closed bars), but not the yeast OST (open bars), 
shows reduced utilization of G2M9GN2-PP-Dol and G1M9GN2-PP-Dol rela-
tive to M5GN2-PP-Dol (bottom).
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of the tripeptide acceptor. The linear Lineweaver-Burk plots for 
the tripeptide acceptors were indicative of a single acceptor tri-
peptide binding site, as observed for the yeast and mammalian 
OST (Karaoglu et al., 2001; Kelleher et al., 2003). The non-
optimal donor substrate (G3M9GN2-PP-Dol for T. vaginalis and 
M5GN2-PP-Dol for T. cruzi) reduces the binding affi nity of the 
OST for the tripeptide acceptor. In both cases, the threefold de-
crease in acceptor tripeptide binding affi nity is responsible for 
the reduction in the normalized transfer rate when the acceptor 
tripeptide is not saturating. The apparent Vmax is not infl uenced 
by the structure of the OS-PP-Dol donor, as revealed by a shared 
I/V intercept, when the oligosaccharide donors are present in 
fourfold excess relative to the apparent Km for the donor sub-
strate (Fig. 6 A).
Discussion
Donor substrate selection 
of nonglucosylated oligosaccharides
GN2-PP-Dol is the smallest oligosaccharide donor that is an ef-
fective substrate for the yeast OST (Sharma et al., 1981; Bause 
et al., 1995; Gibbs and Coward, 1999). The 2′ N-acetyl modifi -
cation on the fi rst saccharide is critical for catalysis, whereas 
the 2′ N-acetyl modifi cation on the second residue is important 
for substrate recognition (Tai and Imperiali, 2001). Effi cient 
N-glycosylation by the OST from higher eukaryotes is also 
dependent on the terminal glucose residue on the A antennae of 
the oligosaccharide (Turco et al., 1977; Trimble et al., 1980). 
As the OS-PP-Dol donors synthesized by many protists and the 
fungi C. neoformans lack glucose residues, one might predict 
that the OST from these organisms would only recognize the 
GlcNAc2 core of the donor substrate. However, donor substrate 
competition experiments demonstrate that the in vivo oligo-
saccharide donor for T. vaginalis, E. histolytica, T. cruzi, and 
C. neoformans is a preferred substrate relative to certain larger 
and/or smaller OS-PP-Dol compounds. To our knowledge, this 
is the fi rst evidence that oligosaccharide donor substrate selec-
tion is not restricted to organisms that synthesize the trigluco-
sylated oligosaccharide donor. In all four cases, preferential 
utilization of the in vivo donor is less stringent than that ob-
served for the S. cerevisiae or mammalian OST both in terms of 
the size range of compounds that are optimal in vitro substrates 
and the fold selection of the in vivo donor substrate relative to 
nonoptimal donors.
The predicted one-subunit OST from T. cruzi utilizes 
larger OS-PP-Dol compounds, including the in vivo donor 
M9GN2-PP-Dol in preference to M5GN2-PP-Dol. The latter 
compound is one of four lumenal OS-PP-Dol assembly inter-
mediates that could compete in vivo with M9GN2-PP-Dol as 
a donor substrate. The observed two- to threefold more rapid 
in vitro transfer of M9GN2-PP-Dol than M5GN2-PP-Dol appears 
to be suffi cient to ensure that small assembly intermediates are 
rarely used in vivo, in part because M9GN2-PP-Dol is more abun-
dant in the T. cruzi ER than the luminally oriented (M5-8GN2-
PP-Dol) assembly intermediates (Parodi and Quesada-Allue, 
1982). The presence of a terminal α-1,2–linked mannose resi-
due on the B or C antennae appears to be important for prefer-
ential utilization of M9GN2-PP-Dol by the T. cruzi OST, as 
revealed by the relative transfer rates of M5GN2-PP-Dol isomer 
classes (Fig. 3) and by the reduced utilization of M3-6GN2-PP-
Dol relative to M9GN2-PP-Dol. In vivo transfer of an assembly 
intermediate may be deleterious, as protein-linked high-mannose 
oligosaccharides that lack the terminal mannose residue on 
the B antennae (M8B isomer) or C antennae (M8C isomer) are 
less effi ciently glucosylated by the UDP-glucose glycoprotein 
Figure 5. Kinetic parameters for the oligosaccharide donor substrate. 
OST activity was assayed using a constant concentration of the acceptor 
tripeptide substrate (10 μM in A, B, and D and 15 μM in C) and variable 
concentrations of M5GN2-PP-Dol (A–C) or M9GN2-PP-Dol (D). (A, C, and D) 
Lineweaver-Burk plots (1/OST activity versus 1/[OS-PP-Dol]) for the 
T. vaginalis (A; Km = 0.22 μM), E. histolytica (C; Km = 0.72 μM), or 
T. cruzi (D; Km = 0.49 μM) OST were linear. (B) An Eadie-Hofstee plot 
(OST activity vs. OST activity/[OS-PP-Dol]) for the T. vaginalis (Km = 0.19 μM) 
OST was linear. The inset shows an Eadie-Hofstee plot for the S. cerevi-
siae OST  using M5GN2-PP-Dol as the donor substrate.
Figure 6. Kinetic parameters for the tripeptide acceptor substrate. OST 
activity was assayed using a constant concentration of the OS-PP-Dol 
donor (1 μM M5GN2-PP-Dol or G3M9GN2-PP-Dol in A and 0.8 μM M5GN2-
PP-Dol or M9GN2-PP-Dol in B) and increasing concentrations of acceptor 
tripeptide substrate. (A) Lineweaver-Burk plots for the T. vaginalis OST 
yielded apparent Km values of 17 μM (M5GN2-PP-Dol donor) and 53 μM 
(G3M9GN2-PP-Dol) for the acceptor tripeptide. (B) Lineweaver-Burk plots for 
the T. cruzi OST yielded apparent Km values of 2.3 μM (M9GN2-PP-Dol 
 donor) and 6.9 μM (M5GN2-PP-Dol) for the acceptor tripeptide.
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glucosyltransferase (UGGT; Trombetta and Parodi, 2003). 
UGGT, which was fi rst detected in T. cruzi, serves as the folding 
sensor for the glycoprotein quality-control pathway in the ER 
(Caramelo et al., 2003).
The predicted four-subunit OSTs from T. vaginalis and 
E. histolytica (Fig. 1) transfer the in vivo donor (M5GN2-PP-Dol) 
at the same rate as other OS-PP-Dol compounds that lack glu-
cose residues (M4-9GN2-PP-Dol), including M5GN2-PP-Dol iso-
mers that lack one or more mannose residues on the A antennae. 
Because synthesis of the M5GN2-PP-Dol donor is completed 
on the cytoplasmic face of the rough ER, the T. vaginalis 
and E. histolytica OST do not need to discriminate between 
luminally oriented M5GN2-PP-Dol and cytoplasmically oriented 
OS-PP-Dol assembly intermediates. Consequently, M5GN2-
NYT is the major glycopeptide synthesized in vitro when 
an acceptor tripeptide is incubated with intact T. vaginalis or 
E. histolytica membranes (Samuelson et al., 2005) despite the 
lack of a mechanism to discriminate against underassembled 
oligosaccharide donors. We propose that the STT3 active-site 
subunit of the OST has evolved to have a catalytic site that 
is optimal for the in vivo oligosaccharide. For T. vaginalis, 
E. histolytica, and C. neoformans, the proposed loss of genes 
that encode the ALG glucosyltransferases (ALG6, -8, and -10; 
Samuelson et al., 2005) has apparently been accompanied by 
compen satory alterations in the STT3 structure that are opti-
mal for an oligosaccharide donor with an A antennae that lacks 
all three glucose residues.
The predicted seven-subunit C. neoformans OST transfers 
the larger mannosylated OS-PP-Dol donors (M7-9GN2-PP-Dol) 
more rapidly than smaller assembly intermediates or G3M9GN2-
PP-Dol. Utilization of the fully assembled in vivo donor in pref-
erence to luminally exposed OS-PP-Dol assembly intermediates 
may be a shared property of the OST in organisms that synthe-
size donors larger than M5GN2-PP-Dol. The relatively modest 
(1.5-fold) preference for M9GN2-PP-Dol relative to biosyn-
thetic M5GN2-PP-Dol leads to selective synthesis of M9GN2-
NYT when the acceptor tripeptide is incubated with intact 
C. neoformans membranes (Samuelson et al., 2005).
Kinetic analysis of the T. cruzi and T. vaginalis OST re-
vealed that oligosaccharide structure–mediated modulation of 
acceptor substrate binding affi nity is a conserved property of the 
eukaryotic OST that can be ascribed to the STT3 active site. 
The threefold reduction in acceptor substrate binding affi nity 
readily accounts for the reduced transfer of nonoptimal donors 
when the acceptor tripeptide is present at subsaturating levels. 
Future studies will address the order of substrate binding to the 
one- and four-subunit OSTs that are predicted for T. cruzi and 
E. histolytica. One objective of these experiments will be to de-
termine whether the subunit composition of protist complexes 
matches the bioinformatic predictions.
Candidate subunits for the regulatory 
OS-PP-Dol binding site
Cooperative OS-PP-Dol binding by the S. cerevisiae OST is not 
explained by dimerization of heterooctamers, as coimmuno-
precipitation experiments using yeast strains that express STT3-
HA3 and STT3-His6FLAG1 from chromosomal loci did not 
reveal higher order OST oligomers (Karaoglu et al., 2001). 
Potential explanations for the discrepancy between a recent re-
port describing dimeric assembly of the yeast OST complex 
(Chavan et al., 2006) and our previous conclusions are being 
explored. Cooperative OS-PP-Dol binding is not explained by 
separate but interacting binding sites for the chitobiose core of 
G3M9GN2-PP-Dol and the terminal glucose residue, because 
cooperative binding by the yeast or canine OST is not depen-
dent on the presence of glucose residues on the oligosaccharide 
donor, as confi rmed here using M5GN2-PP-Dol as a donor 
substrate. Instead, our results indicate that cooperative donor 
substrate binding is diagnostic of a regulatory OS-PP-Dol 
binding site that is primarily responsible for the highly selective 
utilization of the G3M9GN2-PP-Dol donor (Karaoglu et al., 
2001; Kelleher et al., 2003).
Based on a kinetic analysis of canine OST isoforms, we 
proposed that the regulatory OS-PP-Dol binding site is not 
located on the catalytic subunit (STT3A or -B), but is instead 
provided by one or more of the shared noncatalytic subunits. 
Support for this hypothesis has now been provided by recent 
experiments showing that a T. cruzi STT3 can assemble with the 
noncatalytic yeast OST subunits and, upon doing so, mediate 
selective utilization of G3M9GN2-PP-Dol as the donor substrate 
both in vitro and in vivo (Castro et al., 2006).
One objective of this study was to determine whether pro-
tist OSTs use a regulatory OS-PP-Dol binding site to select the 
in vivo oligosaccharide donor. Unlike the S. cerevisiae and Canis 
familiaris OST, the predicted one-subunit OST from T. cruzi 
(STT3) and the predicted four-subunit OSTs from E. histolytica 
and T. vaginalis (STT3-OST1-OST2-WBP1) do not bind OS-
PP-Dol in a cooperative manner; hence, the OST from these 
organisms lacks the regulatory OS-PP-Dol binding site. The 
simplest interpretation of this observation is that the regulatory 
OS-PP-Dol binding arose as additional subunits were acquired 
during evolution of the eukaryotic OST. The IAP and TUSC3 
(N33) proteins dissociate from the canine OST during purifi ca-
tion, so these OST3/OST6 family members are not candidates 
for the regulatory OS-PP-Dol binding site. OST4 and -5 can be 
discounted based on structural considerations because neither 
of these polypeptides has more than a few residues exposed to 
the lumen of the ER (Fig. 1). Therefore, cooperative OS-PP-Dol 
binding by the yeast or vertebrate OST correlates with the pres-
ence of a Swp1p/ribophorin II subunit in the OST complex. 
Extensive biochemical and genetic evidence supports direct 
interactions between Wbp1, Swp1p, and Ost2p (te Heesen 
et al., 1993; Silberstein et al., 1995), as well as between their re-
spective mammalian homologues, OST48, ribophorin II, and 
DAD1 (Fu et al., 1997; Kelleher and Gilmore, 1997). We hy-
pothesize that the regulatory OS-PP-Dol binding site is located 
on the Swp1p–Wbp1p–Ost2p subcomplex. Interestingly, OS-
PP-Dol protects a critical cysteine residue in Wbp1p from mod-
ifi cation by a cysteine-directed protein modifi cation reagent 
(Pathak et al., 1995). A role for the Swp1p–Wbp1p–Ost2p 
subcomplex as the regulatory OS-PP-Dol binding site might 
help explain why expression of each of these subunits is essen-
tial for viability of S. cerevisiae (te Heesen et al., 1992, 1993; 
Silberstein et al., 1995). With the exception of C. neoformans, 
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there is a strong correlation between organisms that assemble a 
glucosylated oligosaccharide donor (either G3M5GN2-PP-Dol 
or G3M9GN2-PP-Dol) and organisms that express or are pre-
dicted to express a Swp1p/ribophorin II homologue (Samuelson 
et al., 2005; Kelleher and Gilmore, 2006).
Materials and methods
Preparation of detergent-extracted membranes and the S. cerevisiae OST
Trophozoites of E. histolytica strain HM1:IMSS were grown axenically (in 
the absence of bacteria or other cells) in TYI medium supplemented with 
10% heat-inactivated adult bovine serum at 37°C. Axenic cultures of 
T. vaginalis strain G3 were maintained in TYM medium supplemented with 
10% heat-inactivated horse serum at 37°C. Axenic cultures of T. cruzi epi-
mastigotes (strain Y) were grown in the LIT medium supplemented with 
hemin and 10% heat-inactivated fetal calf serum at 25°C. C. neoformans 
strain B3501, maintained on YPD plates, was grown in YPD broth for 
20 h at 30°C.
Whole cells were collected by centrifugation and resuspended in 
10 mM Hepes, pH 7.4, 25 mM NaCl, 10 mM MgCl2, and 1× protease 
inhibitor cocktail (PIC; as deﬁ ned by Kelleher et al., 1992). E. histolytica, 
T. vaginalis, or T. cruzi cells were homogenized using 50 strokes of a 
Teﬂ on-glass homogenizer. The C. neoformans cell suspension was mixed 
with an equal volume of glass beads and vortexed extensively (200 5-s 
bursts). Total membrane fractions were collected by a 30-min centrifugation 
of the cell homogenate at 267,000 gav using a rotor (TLA 100.4; Beckman 
Coulter). The membrane pellets were solubilized in 1.5% digitonin, 20 mM 
Tris-Cl, pH 7.5, 500 mM NaCl, 1 mM MgCl2, 1 mM MnCl2, 1 mM DTT, 
and 1× PIC at a membrane concentration of 2 eq/μl (1 eq/μl = 50 A280 
in 1% SDS). The detergent extracts were clariﬁ ed by a 5-min centrifugation 
at 66,600 gav using the rotor. The S. cerevisiae OST was puriﬁ ed from an 
epitope-tagged (6xHisFLAG-OST1) yeast strain as described previously 
(Karaoglu et al., 2001).
OST assays
Detergent extracts of the E. histolytica, T. vaginalis, T. cruzi, and C. neo
formans membranes were diluted fourfold with 20 mM Tris-Cl, pH 7.4, 
1 mM MgCl2, 1 mM MnCl2, 1 mM DTT, and 1× PIC. 5-μl aliquots of the 
4×- diluted soluble extracts were assayed for OST activity in a total volume 
of 100 μl as described previously (Kelleher and Gilmore, 1997), using 
Nα-Ac-Asn-[125I]Tyr-Thr-NH2 as the acceptor substrate and either structur-
ally homogeneous OS-PP-Dol compounds or a previously described hetero-
geneous bovine pancreas OS-PP-Dol pool (Kelleher et al., 2001) as the 
donor substrate. OST assays were supplemented with 1.4 mM deoxynojiri-
mycin, 1.4 mM mannojirimycin, and 1.4 mM swainsonine to inhibit gluco-
sidases and mannosidases. Glycopeptide products from OST assays were 
isolated with ConA Sepharose and quantiﬁ ed by gamma counting.
Structurally homogeneous G3M9GN2-PP-Dol, M9GN2-PP-Dol, M5GN2-
PP-Dol, and an enriched G2M9GN2-PP-Dol preparation were puriﬁ ed 
as described previously (Kelleher et al., 2001) from porcine pancreas 
(G3M9GN2-PP-Dol and G2M9GN2-PP-Dol), an alg5∆ yeast strain (M9GN2-
PP-Dol), or an alg3∆ yeast strain (M5GN2-PP-Dol).
The concentration and composition of OS-PP-Dol samples was deter-
mined from the yield and oligosaccharide distribution of radiolabeled glyco -
peptides obtained in the OST endpoint assay (Kelleher et al., 2001). In 
brief, 12–15 pmol of OS-PP-Dol was incubated with 60 fmol of puriﬁ ed 
yeast OST for 24–48 h under OST assay conditions to quantitatively 
convert the donor substrate into glycopeptides. The previously isolated het-
erogeneous bovine pancreas OS-PP-Dol pool consists of a mixture of bio-
synthetic OS-PP-Dol assembly intermediates and OS-PP-Dol degradation 
products that were produced by exposure of the OS-PP-Dol to endogenous 
mannosidases and glycosidases during isolation (Kelleher et al. 2001). As 
shown in Fig. S1 B, the bovine OS-PP-Dol pool has the following oligosac-
charide composition: 4.7% M3GN2, 14% M4GN2, 19% M5GN2, 23% 
M6GN2,17% M7GN2, 11% M8GN2, 3.7% M9GN2, 1% G1M9GN2, 1.5% 
G2M9GN2, and 5.1% G3M9GN2. Because of low abundance in the 
donor pool, initial transfer rates are not reported for G1M9GN2-PP-Dol and 
G2M9GN2-PP-Dol.
Assays designed to analyze the donor substrate preference of the 
OST using the bovine OS-PP-Dol library contained 1.2 μM OS-PP-Dol and 
were terminated before 3% of the total donor was consumed. Donor sub-
strate competition experiments using puriﬁ ed donors were terminated be-
fore 10% of the substrate was consumed. Glycopeptide products from the 
competition experiments were eluted from the ConA beads and resolved 
according to oligosaccharide size by HPLC as described previously 
(Mellis and Baenziger, 1981; Kelleher et al., 2001), except that the HPLC 
buffer A was acetonitrile/water/acetic acid/triethlyamine (73.6:23:2.4:1), 
whereas HPLC buffer B was water/acetic acid/triethlyamine (91:3:6). Glyco-
peptides prepared using the yeast OST and puriﬁ ed OS-PP-Dol compounds 
served as HPLC elution standards.
Digestions of M5GN2-NYT with 𝛂-1,2 mannosidase
OST assays to prepare M5GN2 glycopeptides using the heterogeneous 
OS-PP-Dol library were designed to ensure that <10% of the total M5GN2-
PP-Dol was converted to M5GN2-NYT. HPLC fractions corresponding to 
M5GN2-NYT were dried and resuspended in 50 μl of 1× reaction buffer 
supplied by the manufacturer (Prozyme) and incubated for 18 h at 37°C 
with 0.33 mU α-1,2 mannosidase. The Savant-dried glycopeptide diges-
tion products were dissolved in 500 μl HPLC buffer A and resolved by 
HPLC as described in the preceeding paragraph.
Analysis of kinetic data
The kinetic parameters for the tripeptide acceptor and oligosaccharide 
donor for the T. vaginalis, T. cruzi, and E. histolytica enzymes were deter-
mined by a nonlinear least-squares ﬁ t of the kinetic data to the Michaelis-
Menten equation and by linear least-squares ﬁ ts of Lineweaver-Burk plots 
or Eadie-Hofstee plots. The kinetic parameters for the dolichol-oligosac-
charide  donor for the S. cerevisiae enzyme were obtained using a nonlin-
ear least-squares ﬁ t of the kinetic data to equations for a substrate activated 
enzyme as described previously (Karaoglu et al., 2001). Kaleidagraph 
3.5 (Synergy Software) was used for curve ﬁ tting.
Online supplemental material
Fig. S1 shows the oligosaccharide composition analysis of the OS-PP-Dol library 
used for the experiments in Fig. 2 and Fig. 3. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200611079/DC1.
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